Literature DB >> 25783160

Dysregulation of microRNA biogenesis and gene silencing in cancer.

Akiko Hata1, Judy Lieberman2.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that suppress the abundance of partially complementary mRNAs and inhibit their translation. Each miRNA can regulate hundreds of mRNAs, sometimes strongly but often weakly, to mediate a diverse array of biological functions, including proliferation, cell signaling, differentiation, stress responses and DNA repair, cell adhesion and motility, inflammation, cell survival, senescence, and apoptosis, all intimately related to cancer initiation, treatment response, and metastasis. The expression and activity of miRNAs are spatially and temporally controlled. Global miRNA expression is reduced in many cancers. In addition, the expression and processing of cancer-related miRNAs that act as oncogenes ("oncomiRs") or tumor suppressors are often dysregulated in cancer. In this review, we summarize emerging knowledge about how miRNA biogenesis and gene silencing are altered to promote cancer.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25783160     DOI: 10.1126/scisignal.2005825

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  90 in total

Review 1.  Dysregulation of microRNA biogenesis machinery in cancer.

Authors:  Akiko Hata; Risa Kashima
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-12-01       Impact factor: 8.250

Review 2.  A network-biology perspective of microRNA function and dysfunction in cancer.

Authors:  Cameron P Bracken; Hamish S Scott; Gregory J Goodall
Journal:  Nat Rev Genet       Date:  2016-10-31       Impact factor: 53.242

3.  Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.

Authors:  Mallory E Harden; Karl Munger
Journal:  Virology       Date:  2017-04-24       Impact factor: 3.616

4.  G-Quadruplexes influence pri-microRNA processing.

Authors:  Samuel G Rouleau; Jean-Michel Garant; François Bolduc; Martin Bisaillon; Jean-Pierre Perreault
Journal:  RNA Biol       Date:  2017-12-11       Impact factor: 4.652

Review 5.  Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia.

Authors:  Akiko Hata; Giorgio Lagna
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

6.  Integrative analysis of signaling pathways and diseases associated with the miR-106b/25 cluster and their function study in berberine-induced multiple myeloma cells.

Authors:  Chunming Gu; Tianfu Li; Zhao Yin; Shengting Chen; Jia Fei; Jianping Shen; Yuan Zhang
Journal:  Funct Integr Genomics       Date:  2016-09-19       Impact factor: 3.410

Review 7.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 8.  Knocking down disease: a progress report on siRNA therapeutics.

Authors:  Anders Wittrup; Judy Lieberman
Journal:  Nat Rev Genet       Date:  2015-09       Impact factor: 53.242

Review 9.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

10.  MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.

Authors:  Haijian Wu; Yan Liu; Xiao Ou Shu; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2016-03-31       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.